Skip to main content

Advertisement

SpringerLink
Log in

Overlap Between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease

A Clinical Pathology Conference held by the Department of Rheumatology at Hospital for Special Surgery

  • Clinical Pathology Conference
  • Published:
HSS Journal

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Jang YJ, Park KH Seok HJ (2000) Management of Kikuchi’s disease using glucocorticoid. J. Laryngol. Otol. 114:709–11

    Article  PubMed  CAS  Google Scholar 

  2. Rezai K, Kuchipudi S, Chundi V (2004) Kikuchi–Fujimoto disease: hydroxychloroquine as a treatment. Clin. Infect. Dis 39:e124–e126

    Article  PubMed  Google Scholar 

  3. Lawrence RC, Helmick CG, Arnett FC (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 41:778–799

    Article  PubMed  CAS  Google Scholar 

  4. Jimenez S, Cervera R, Font J (2003) The epidemiology of systemic lupus erythematosus. Clin. Rev. Allergy Immunol. 25:3–12

    Article  PubMed  Google Scholar 

  5. El-Ramahi KM, Karrar A, Ali MA (1994) Kikuchi disease and its association with systemic lupus erythematosus. Lupus 3:409–11

    Article  PubMed  CAS  Google Scholar 

  6. Goldblatt F, Andrews J, Russell A, Isenberg D (2008) Association of Kikuchi–Fujimoto’s disease with SLE. Rheumatology 47:554–555

    Google Scholar 

  7. Eisner MD, Amory J, Mullaney B (1996) Necrotizing lymphadenitis associated with systemic lupus erythematosus. Semin. Arthritis Rheum. 26:1–6

    Article  Google Scholar 

  8. Ohshima K, Karube K, Hamasaki M (2004) Apoptosis- and cell cycle-associated gene expression profiling of histiocytic necrotising lymphadenitis. Eur. J. Haematol. 72:322–9

    Article  PubMed  CAS  Google Scholar 

  9. Kato K, Ohshima K, Anzai K (2001) Elevated serum-soluble Fas ligand in histiocytic necrotizing lymphadenitis. Int. J. Hematol. 73:84–6

    Article  PubMed  CAS  Google Scholar 

  10. Kozyrev SV, Lewén S, Reddy PM (2007) Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum 56:1234–41

    Article  PubMed  CAS  Google Scholar 

  11. Niewold TB, Kelly JA, Flesch MH (2008) Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum. 58:2481–7

    Article  PubMed  CAS  Google Scholar 

  12. Graham RR, Kyogoku C, Sigurdsson S, et al. (2007) Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A. 104:6758–6763

    Google Scholar 

  13. Kirou KA, Mavragani CP, Crow MK (2007) Activation of typeI interferon in systemic lupus erythematosus. Expert Rev. Clin. Immunol. 3:579–588

    Google Scholar 

  14. Barrat FJ, Meeker T, Gregorio J, et al. (2005) Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202:1131–1139

    Google Scholar 

  15. Cella M, Jarrossay D, Facchetti F (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:919–923

    Article  PubMed  CAS  Google Scholar 

  16. Qu C, Moran TM, Randolph GJ (2003) Autocrine type I IFN and contact with endothelium promote the presentation of influenza A virus by monocyte-derived APC. J. Immunol 170:1010–1018

    PubMed  CAS  Google Scholar 

  17. Tsang WY, Chan JK, Ng CS (1994) Kikuchi’s lymphadenitis. A morphologic analysis of 75 cases with special reference to unusual features. Am. J. Surg. Pathol. 18:219–231

    Article  PubMed  CAS  Google Scholar 

  18. Heremans H, Billiau A, Colombatti A (1978) Interferon treatment of NZB mice: accelerated progression of autoimmune disease. Infect. Immun. 21:925–930

    PubMed  CAS  Google Scholar 

  19. Braun D, Geraldes P, Demengeot J (2003) Type I interferon controls the onset and severity of autoimmune manifestations in lpr mice. J. Autoimmun. 20:15–25

    Article  PubMed  CAS  Google Scholar 

  20. Adam C, Thoua Y, Ronco P (1980) The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice. Clin. Exp. Immunol. 40:373–382

    PubMed  CAS  Google Scholar 

  21. Mathian A, Weinberg A, Gallegos M (2005) IFN-{alpha} induces early lethal lupus in preautoimmune (New Zealand Black × New Zealand White) F1 but Not in BALB/c Mice. J. Immunol. 174:2499–2506

    PubMed  CAS  Google Scholar 

  22. Santiago-Raber ML, Baccala R, Haraldsson KM (2003) Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice. J. Exp. Med. 197:777–788

    Article  PubMed  CAS  Google Scholar 

  23. Hron JD, Peng SL (2004) Type I IFN protects against murine lupus. J. Immunol. 173:2134–2142

    PubMed  CAS  Google Scholar 

  24. Baechler EC, Batliwalla FM, Karypis G (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 100:2610–2615

    Article  PubMed  CAS  Google Scholar 

  25. Crow MK, Kirou KA, Wohlgemuth J (2003) Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 36:481–490

    Article  PubMed  CAS  Google Scholar 

  26. Bennett L, Palucka AK, Arce E (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197:711–723

    Article  PubMed  CAS  Google Scholar 

  27. Kirou KA, Lee C, George S (2004) Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum. 50:3958–3967

    Article  PubMed  CAS  Google Scholar 

  28. Farkas L, Beiske K, Lund-Johansen F (2001) Plasmacytoid dendritic cells (natural interferon- {{alpha}}/{beta}-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159:237–243

    PubMed  CAS  Google Scholar 

  29. Blomberg S, Eloranta ML, Cederblad B (2001) Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus 10:484–490

    Article  PubMed  CAS  Google Scholar 

  30. Nakano H, Yanagita M, Gunn MD (2001) CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194:1171–1178

    Article  PubMed  CAS  Google Scholar 

  31. Yoneyama H, Matsuno K, Toda E (2005) Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J. Exp. Med. 202:425–435

    Article  PubMed  CAS  Google Scholar 

  32. Shiow LR, Rosen DB, Brdickova N, et al., CD69 acts downstream of interferon-[alpha]/[beta] to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006; 440: 540–544.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA

    Jessica K. Gordon MD, Theresa Lu MD, PhD, Anne Bass MD & Doruk Erkan MD

  2. Department of Dermatopathology, Weill-Cornell Medical College-New York Presbyterian Hospital, 546 East 68th Street, New York, NY, 10021, USA

    Cynthia Magro MD & Garron Solomon MD

  3. Department of Radiology, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA

    Robert Schneider MD

  4. Department of Pathology, Weill-Cornell Medical College-New York Presbyterian Hospital, 525 East 68th Street, New York, NY, 10021, USA

    April Chiu MD

  5. Division of Hematology and Oncology, Weill-Cornell Medical College–New York Presbyterian Hospital, 525 East 68th Street, New York, NY, 10021, USA

    Richard R. Furman MD

Authors
  1. Jessica K. Gordon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cynthia Magro MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Theresa Lu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert Schneider MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. April Chiu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Richard R. Furman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Garron Solomon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Anne Bass MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Doruk Erkan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jessica K. Gordon MD.

Additional information

Each author certifies that he or she has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.

Each author certifies that his or her institution has approved the reporting of this case, that all investigations were conducted in conformity with ethical principles of research.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gordon, J.K., Magro, C., Lu, T. et al. Overlap Between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease. HSS Jrnl 5, 169–177 (2009). https://doi.org/10.1007/s11420-009-9123-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11420-009-9123-x

Keywords

Search

Navigation